ArticleCurrent microbiology2025
Impact of Milk-Derived Microbial Transfer and 7-Epiclusianone on Pathogen Load in Goat Mastitis.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exploratory assessment of milk biomarkers during non‑antibiotic treatment in experimental Staphylococcus warneri goat mastitis.World journal of microbiology & biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mastitis remains a major challenge in dairy goat farming, and the increasing prevalence of antibiotic-resistant pathogens highlights the urgent need for alternative management strategies. This pilot study evaluated the feasibility of a sequential protocol combining intramammary milk-derived microbial transfer (MMT) with 7-epiclusianone in an experimental Staphylococcus warneri-induced caprine mastitis model. Six healthy primiparous Parda Alpina goats were infected in the right udder with S. warneri and received MMT for nine consecutive days from a screened healthy donor. Two days after MMT, intramammary 7-epiclusianone was administered for 7 days. Left udders served as uninfected controls. Pathogen load was assessed using a singleplex S. warneri-specific Polymerase Chain Reaction (PCR) and a multiplex real-time PCR panel targeting common mastitis-associated pathogens. Sequential treatment was well tolerated, and preliminary trends suggested reduced detection intensity of S. warneri, particularly following 7-epiclusianone administration. Changes in detection patterns were also observed for other pathogens. This study demonstrates the feasibility and safety of integrating MMT with a phytocompound-based intervention for managing intramammary infection in an experimental goat mastitis model. While preliminary results suggest potential for pathogen modulation, these findings require confirmation in larger, independently controlled trials to determine individual and combined effects and to rule out contributions from natural immune resolution.
Indexed as
Identifiers
41134375What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.